Actively Recruiting
Prospective Observational Study of Naturopathic Approaches to IBS
Led by National University of Natural Medicine · Updated on 2024-12-06
50
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
N
National University of Natural Medicine
Lead Sponsor
G
Gastroenterology Association of Naturopathic Physicians
Collaborating Sponsor
AI-Summary
What this Trial Is About
Irritable bowel syndrome (IBS) is a common condition affecting about 4% of people worldwide and can significantly impact quality of life and healthcare costs. While there are medications available, few are consistently effective, leading many people with IBS to explore alternative treatments, including naturopathy. However, research on naturopathic approaches to IBS is limited. This study aims to describe how naturopathy is used to treat IBS and to collect preliminary data on changes in IBS symptoms before and after treatment. It will use a prospective, observational design without a control group, focusing on outcomes from individualized naturopathic care provided by licensed practitioners. Adult patients with diagnosed IBS or IBS-like symptoms will be recruited from naturopathic doctors affiliated with the Gastroenterology Association of Naturopathic Physicians. Participants' IBS symptoms will be assessed using validated tools (IBS-SSS and IBS-AR), and quality of life will be measured using the PROMIS-29 survey. Treatment details and any adverse effects will also be recorded. The main outcome will be the difference in symptoms and quality of life after 12 weeks of treatment. Results will be analyzed with statistical tests (p-value \< 0.05) and summarized. The findings from this pilot study will help fill knowledge gaps and provide a foundation for designing a more rigorous randomized controlled trial in the future.
CONDITIONS
Official Title
Prospective Observational Study of Naturopathic Approaches to IBS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (18 years of age or older) with a pre-existing IBS diagnosis or IBS-like gastrointestinal symptoms
- IBS diagnosis or IBS-like symptoms must be the primary reason for the visit
- IBS diagnosis must be listed within the top 3 diagnoses for the visit and addressed in the treatment plan
You will not qualify if you...
- Inability to read and write in English
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Helfgott Research Institute - National University of Natural Medicine
Portland, Oregon, United States, 97201
Actively Recruiting
Research Team
J
Joshua Goldenberg, ND
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here